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Introduction
Based on the latest World Health Organization (WHO) esti-
mates of December 2016, there were 212 million cases of 
malaria in 2015 and 429 000 deaths, with sub-Saharan Africa 
accounting for 90% of all malaria deaths in the world.1 This 
staggering number of deaths resulting from malaria is associ-
ated with the continuous spread of Plasmodium falciparum 
resistance to available antimalarial drugs, posing severe threats 
to existing malaria control programs. The lack of a deployable 
malaria vaccine coupled with increasing cases of drug-resistant 
infections makes the search for new antimalarials imperative.2,3 
Owing to the high cost of malaria treatment in developing 
countries in general and Nigeria in particular, many have 
resulted to consulting traditional herbalists or the use of medic-
inal plants for treatment of infection.4
For thousands of years, in various parts of the world, tradi-
tional herbal medicines have been used to treat malaria.5–9 Two 
of the most important antimalarial drugs in use, artemisinin 
and quinine, were either derived directly from plants or synthe-
sized using chemical structures of plant-derived compounds as 
templates.5,9,10 Most of the people in malaria endemic coun-
tries still depend on traditional herbal remedies, which could 
be linked to limited availability as well as unaffordability of 
existing pharmaceutical drugs.11
Blighia sapida, also referred to as ackee or ackee apple, is a 
medicinal plant of the family Sapindaceae that naturally exists 
in the forests of most West African countries, where the fruits 
are used for several purposes, but rarely eaten.12 When mixed 
with water, the green fruits of this plant produce lather and are 
used for laundry, in addition to its seeds being used for making 
soap due to its high oil content.13 Some parts of this plant also 
serve medicinal purposes, such as the juice from the leaf is tra-
ditionally used to treat conjunctivitis,12 whereas its twiggy 
leaves, once beaten into a pulp, are applied to the forehead for 
treating migraine or headaches.14 For over 20 years, the Centre 
for Scientific Research into Plant Medicine (CSRPM) in 
Ghana has used this plant for the treatment of diarrhea.15 The 
antidiarrheal activity of the stem bark of B sapida has also been 
reported,16 including reports on its traditional use for the treat-
ment of dysentery, yellow fever, burns, wounds, or conjunctivi-
tis, etc.14 Murine experiments have also demonstrated its utility 
in treating pancreatic β-cell dysfunction,17 elevated blood glu-
cose, dyslipidemia, and oxidative stress in alloxan-induced dia-
betic rats.18
In view of the significant challenges imposed by drug resist-
ance, traditional plant extracts continue to be promising sources 
of new antimalarial compounds.9 The use of traditional medi-
cines for the treatment of malaria and other diseases continues to 
be a growing practice among many African families, despite the 
availability of orthodox method of treatment.19 In addition, the 
short supply of artemisinin compounds leading to alternative 
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production methods,9 as well as the desire for low-cost drug 
delivery strategies,7 has led to significant research efforts to deci-
pher alternative plant products that could serve as effective anti-
malarials, especially in sub-Saharan Africa. In this report, the 
antiplasmodial effect of ethanolic extract of B sapida stem bark in 
vivo is reported, using the suppressive, curative, and prophylactic 
model.
Materials and Methods
Plant collection, authentication, and extract 
preparation
The stem bark of B sapida was collected in December 2014 
from Ipetumodu in the South West of Nigeria. Plant material 
was identified in the herbarium of the Botany Department of 
Obafemi Awolowo University, Ile-Ife, Osun State Nigeria with 
voucher number IFE-17629 by Mr GA Ademoriyo. The stem 
bark was air-dried at room temperature and powdered. About 
50 g of the powdered plant was macerated in 500 mL of 99% 
methanol (1:10 W/V) for 48 hours and then filtered. With the 
aid of a rotatory evaporator, filtrate was concentrated to dry-
ness and the residue obtained was stored until future use.
Ethical consideration
Experimental procedures and protocols used in this study were 
in conformity with National Institute of Health’s recommen-
dations in guide for the care and use of laboratory animals and 
in accordance with the principles of Helsinki Declaration.
Parasite/infection
Chloroquine-resistant P berghei ANKA, obtained from 
Institute for Medical Research and Training (IMRAT), 
University College Hospital, Ibadan, Nigeria, was used to eval-
uate the antimalarial activity of B sapida in this study. Groups 
of Swiss albino mice (5 per cage) were infected intraperito-
neally with 1 × 107 parasitized erythrocytes from an infected 
donor mouse. The day of infection was defined as day 0 (D0) 
and subsequent days D1, D2, etc.
Antimalarial medication
Standard Coartem (Artemether and Lumefantrine), used for 
treating malaria (Mekophar Chemical Pharmaceutical Joint-
Stock Co, Ho Chi Minh City, Vietnam) and obtained from a 
pharmacy, was used as reference for the antimalarial screening 
in this study.
Acute toxicity test (assessment of minimum lethal 
dose)
The assessment of minimum lethal dose was done in 2 phases, 
following published methods.20 In phase 1, groups of 3 mice in 
each group were given oral doses of 10, 100, and 1000 mg/kg 
body weight of B sapida ethanolic extract, respectively, and 
observed for 24 hours for mortality. In phase 2, 3 mice in each 
group groups were orally administered with 1600, 2900, and 
5000 mg/kg body weight of the extract, respectively, and moni-
tored for 24 hours, observing for mortality. The phase 2 study 
was conducted because we observed no deaths among animals 
in phase 1 study. The lethal dose and the penultimate dose to 
the lethal dose would indicate the value of the LD50.21,22
In vivo antiplasmodial determination
Swiss albino mice (weight: 18-25 g), obtained from the 
Animal House, Department of Pharmacology, University of 
Ibadan, kept according to Institutional Animal Care and Use 
Committee (IACUC) standards, were allowed to acclimatize 
to the new environment for a week before study initiation. 
Each mouse was inoculated with 0.2 mL of infected blood 
containing about 1 × 107 dose of P berghei berghei (about 
16.6%) from a donor mouse. Each mouse was inoculated on 
day 0 (D0) (intraperitoneally) for the suppressive and cura-
tive model and on the fifth day (D4) for the prophylactic 
model.
Suppressive test (4-day test)
The 4-day suppressive test was conducted according to the 
method of Peters (1975). In this, 25 mice distributed into 5 
groups of 5 mice each were infected with 1 × 107 of parasitized 
red blood cells on day 0. Animals in group 1 received normal 
saline, those in groups 2 to 4 received 200, 400, and 800 mg/kg 
of ethanol extract of B sapida test extract, whereas those in 
group 5 (positive control) received 10 mg/kg of the standard 
drug Coartem. Treatment was administered orally and contin-
ued daily for the next 3 days for the group that received 
Coartem or 4 consecutive days for extract-treated group. On 
day 4, blood samples were collected from the caudal vein and 
stained with 10% Giemsa stain. Thereafter, the number of the 
parasitized cells was estimated under the microscope using 
×100 objective.23 The numbers of infected erythrocytes were 
counted until 1000 erythrocytes were achieved. The average 
percentage suppression of parasitemia was calculated in com-
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Prophylactic test
The prophylactic activity of the extract was performed as 
described previously.24 In this, Swiss albino mice were rand-
omized into 5 groups of 5 mice each: group 1 was treated with 
normal saline only, groups 2 to 4 were treated with 200, 400, 
and 800 mg/kg/d of the ethanol extract of B sapida, and group 
Otegbade et al 3
5 served as positive control (treated with 10 mg/kg/d of the 
standard drug Coartem). Treatment started on day 0 and con-
tinued for 4 consecutive days, by which mice were inoculated 
intraperitoneally with 1 × 107 of the parasite. On day 7 
(72 hours after inoculation), blood smears made from each 
mouse were stained with Giemsa, number of the parasitized 
cells was estimated, and the percentage suppression was 
evaluated.
Curative test
This was also performed with standard protocol,24 as previ-
ously described. Twenty-five mice distributed into 5 groups of 
5 were infected intraperitoneally on the first day (day 0) with 
0.2 mL of parasite inoculum. After 72 hours of infection, all 
animals were treated with different regimens: group 1 received 
normal saline only; groups 2 to 4 received 200, 400, and 800 mg/
kg body weight of plant extract, respectively; whereas group 5 
received 10 mg/kg body weight of the standard antimalarial 
drug (Coartem). Treatment was continued for 5 consecutive 
days, blood smears were made and microscopically examined to 
monitor the degree of parasitemia as well as estimating the 
number of parasitized cells.
Histologic procedures
These were performed with hematoxylin and eosin procedures.25 
Briefly, organs such as liver, spleen, kidney, and testes from each 
animal were fixed in 10% formal saline, grossed and cut longitu-
dinally into pieces of 4 mm in thickness, and processed for histo-
logic study using standard procedure. Microtome sections were 
dried on a hot plate and later stained with hematoxylin and eosin 
stains for examination with a light microscope.
Data analysis
Percentage parasitemia and mean chemosuppression were 
determined using 1-way analysis of variance; Student-
Newman-Keuls test was used for analysis and comparing of 
results at 95% confidence interval; P < .05 was set for statistical 
significance.
Results
About 11.10 g of brown crude extract was obtained from the 
extraction procedure, a percentage yield of 22%. The acute tox-
icity test revealed that the extract appeared to be nontoxic at 
the highest dose (5000 mg/kg) tested. No toxic symptoms or 
mortality was observed in any of the 3 animals in 3 groups both 
in phase 1 and phase 2 acute toxicity test study. All animals 
were still alive at the end of the acute toxicity test, with LD50 
value greater than 5000 mg/kg body weight, showing the 
extract to be nontoxic. Histology sections of the liver, spleen, 
kidney, and testes reveal normal tissue morphology at all doses, 
except at 5000 mg/kg (black ring), where we observed a mild 
perivascular infiltration of liver inflammatory cells (Figure 1); 
otherwise, hepatocytes appeared normal.
Suppressive effect of B sapida ethanolic extract on P 
berghei
In the suppressive test, mean parasitemia on day 4 after infec-
tion ranged from 14.20 ± 1.17 to 18.96 ± 0.60 for 200 and 
800 mg/kg, respectively (Figure 2). The value for control was 
19.02 ± 1.20, whereas for Coartem was 8.38 ± 0.39. The percent-
age chemosuppression of the extract ranged from 6.8% to 0.3% 
for 200 and 800 mg/kg, respectively, whereas that for standard 
antimalarial Coartem was 55.9%. Percentage chemosuppression 
showed increases with decrease in dose levels of the extract, 
indicating that maximal chemosuppression could be reached at 
the lowest dose, although intangible. Percentage chemosuppres-
sion in Coartem was very much higher than in control and all 
the doses of the extract, revealing that extract had little or no 
suppressive effect at all doses. Percentage parasitemia in control, 
compared with 400 and 800 mg/kg, was not statistically signifi-
cant (P > .05), whereas that of 200 mg/kg compared with con-
trol, 400 and 800 mg/kg, was statistically significant (P < .01) 
(Figure 2). Percentage parasitemia in Coartem was much lower 
than in extract at the highest dose, showing statistical signifi-
cance (P < .001), but percentage parasitemia of the lowest dose 
of the extract was slightly higher in comparison with Coartem, 
with the difference not significant (Figure 2).
Prophylactic effect of B sapida ethanolic extract on 
P berghei
The percentage parasitemia in mice infected and treated with 
200, 400, and 800 mg/kg was 8.22 ± 0.32, 9.7 ± 0.31, and 
12.12 ± 0.54, respectively (Figure 3). Untreated saline group had 
percentage parasitemia of 19.10 ± 0.33, whereas that of 
Coartem-treated positive control was 7.24 ± 0.91. Percentage 
chemosuppression of parasites in mice treated with 200, 400, 
Figure 1. Photomicrographs of liver and kidney at the end of acute 
toxicity assessment. (A) Normal liver morphology. (B) (Black ring) mild 
perivascular infiltration of the liver inflammatory cells after treatment with 
5000 mg/kg of the extract. (C) Normal kidney morphology. (D) Kidney 
remains normal after treatment with 5000 mg/kg of the extract. 
Haematoxylin and Eosin, 400x original magnification.
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and 800 mg/kg was 57%, 50.8%, and 36.5%, respectively, 
whereas that of Coartem was 62.1%. Unlike our observation in 
the suppressive model, percentage parasitemia decreased with a 
decrease in extract dose levels, showing that a tangible optimal 
Figure 2. Suppressive effect of methanol extract of bark of Blighia sapida on Plasmodium berghei. Bars are expressed as mean ± SEM (n = 5); ***P < .001, 
Coartem versus normal saline (NS); **P < .01, 200 mg/kg versus normal saline.
Figure 3. Prophylactic effect of ethanol extract of Blighia sapida on Plasmodium berghei in mice. Bars are expressed as mean ± SEM (n = 5); ***P < .001, 
test and control versus normal saline (NS).
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chemosuppression can be obtained at the lowest dose in this 
model and is statistically significant at all doses when compared 
with nontreated group (P < .001; Figure 3). The percentage of 
the extract at the lowest dose (200 mg/kg) was comparable with 
that of Coartem, although Coartem exhibited a highly signifi-
cant (P < .001) decrease in percentage parasitemia compared 
with negative control and 800 mg/kg.
Curative effect of B sapida ethanolic extract on P 
berghei
Figure 4 shows curative effect of the extract at different graded 
doses. Unlike the suppressive and prophylactic models, none of 
the extract doses tested showed significant activity. The lowest 
dose (200 mg/kg) that had shown significant activity in other 
models showed no activity in our model. For day 3, the values 
for Coartem versus control versus 200 mg/kg of the extract was 
1.74 ± 0.29 versus 7.58 ± 0.44 versus 7.18 ± 0.82, with similar 
findings on day 7 (21.48 ± 0.68, 17.00 ± 0.58, and 2.06 ± 0.39 for 
control), 200 mg/kg of extract and Coartem, respectively, 
revealing the extract had no significant activity against the 
parasite when compared with control.
Effect of malaria on weight of malaria-induced 
mice
The weights of all test animals decreased 24 hours after infec-
tion, with this decrease continuing among the suppressive, 
curative, and untreated groups 72 hours after treatment. 
However, by day 5 (21.40 ± 1.20), this progressive weight loss 
was turned around for the prophylactic group when compared 
with the weights obtained at the same dose on day 0 
(20.78 ± 0.92) and day 7 (21.70 ± 1.08) (Table 1).
Effect of B sapida ethanolic extract on organs of P 
berghei–infected mice
The kidney, liver, and spleen of the mice revealed normal tissue 
architecture after treatment, demonstrating that this extract 
appears safe on the major organs of the mice (slides not shown).
Figure 4. Curative effect of ethanol extract of Blighia sapida on Plasmodium berghei in mice. NS indicates normal saline.
Table 1. Weights of mice for prophylactic model.
DOSE, 
Mg/Kg
DAy 0 DAy 1 DAy 2 DAy 3 DAy 4 DAy 5 DAy 6 DAy 7
NS 21.40 ± 1.02 21.85 ± 0.99 22.08 ± 1.0 21.94 ± 0.96 22.28 ± 1.10 21.90 ± 0.93 19.45 ± 0.83 17.02 ± 0.75
200 20.78 ± 0.92 20.16 ± 0.94 21.02 ± 1.02 20.24 ± 1.10 20.96 ± 1.03 21.40 ± 1.20 20.16 ± 1.00 21.70 ± 1.08
400 17.28 ± 0.44 17.20 ± 0.39 17.46 ± 0.54 17.36 ± 0.51 17.62 ± 0.41 18.00 ± 0.47 17.32 ± 0.43 16.96 ± 0.40
800 22.28 ± 1.21 22.20 ± 1.40 22.50 ± 1.47 21.64 ± 1.33 22.12 ± 1.34 22.80 ± 1.52 21.90 ± 1.36 22.68 ± 1.44
Coartem 19.58 ± 1.00 19.88 ± 0.90 20.14 ± 0.78 19.78 ± 0.70 19.58 ± 0.70 20.12 ± 0.75 19.52 ± 0.63 20.42 ± 0.51
Abbreviation: NS, normal saline.
The baseline weights were taken before inoculation and subsequent weights taken before, during and after treatments. Data are expressed as 
mean ± SEM. Values do not indicate statistical significance to one another.
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Survival time of mice in the 3 models
The survival time for mice in the prophylactic group was longer 
than those in suppressive and curative groups (Figure 5). Mice 
in prophylactic group started dying on day 9, whereas most 
were still alive at day 20 and beyond. However, animals in cura-
tive group started dying on day 5 and were all dead by day 9, 
whereas those in the suppressive group started dying on day 5 
with 98% dead by day 11. These results clearly demonstrate the 
prophylactic effect of this extract, at different doses, on malaria-
infected animal.
Discussion
Despite the many and varying efforts at malaria control, this 
disease is still a global threat of enormous proportion and a 
significant contributor to health and economic inequities in 
endemic countries. Inhabitants of these countries, under the 
scourge of disease, face the conundrum of finding appropriate, 
effective, and cheap means to protect themselves against infec-
tion, whereas the parasite, however, has shown an increasing 
resistance to available antimalarial drugs. This resistance is also 
favored by population movement and human migration lead-
ing to the introduction of resistant parasite to areas previously 
free of drug resistance. The possibility of synthesizing new 
antimalarials from plants has become a major policy goal in the 
control arena, becoming more urgent, in light of the limited 
number of antimalarials in development, the potential of para-
site resistance to the only available therapeutic drugs (arte-
misinin and its derivatives), and the poor solubility of 
artemisinin. These are some of the factors driving the design of 
alternative methods of artemisinin delivery that could poten-
tially slow the process of resistance evolution.10,26,27 We dem-
onstrate that B sapida investigated in this study possesses 
antimalarial properties that deserve further analysis and could 
become a cheap, readily available antimalarial in developing 
countries.
This study shows that B sapida has remarkable activity 
(almost equivalent with Coartem), when used as a prophylac-
tic agent in chloroquine-resistant P berghei–infected mice, 
with the 7-day assay leading to a significant parasitemia sup-
pression. Maximum activity was recorded at the lowest dose 
(200 mg/kg), with a decrease with increasing dosage, implying 
that the extract had no pronounced activity at higher doses, 
and that the small dose suffices to produce significant antima-
larial activity. This observation concurs with previous result, 
where the minimum inhibitory activity shown by the metha-
nolic extract of B sapida against Staphylococcus aureus started at 
a dose of 200 mg/mL, but further increase in activity was seen 
as the dose was decreased to 100 mg/mL, suggesting that the 
lower the dose, the higher the activity displayed.28 It is worth 
noting that B sapida extract exhibited the most active antiplas-
modial properties at the lowest dosage tested. This dose-
dependent activity potentially shows that response at low dose 
is more effective than response inhibition at high dose.29 Our 
results show that B sapida extracts will serve as excellent anti-
malarial agent in the prophylactic model of treatment.
The absence of death after administering 5000 mg/kg body 
weight of B sapida extract in the acute toxicity test suggests that 
the extract appears to be nontoxic, an observation supported by 
the toxicity scale principle, which states that any chemical 
showing an LD50 greater than 5000 mg/kg is practically non-
toxic.30 In this report, the acute toxicity test conducted with the 
extracts demonstrate their safety because the highest dose 
caused no death. Interestingly, the highest dose used to treat 
parasite-infected mice from which antimalarial activity was 
elicited was much lower than the highest acute dose, thus mak-
ing the extract quite selective and safe.
Loss of appetite, ultimately leading to weight loss, is one of 
the characteristics of malaria infection.31 We observed weight 
loss in P berghei–infected animals after infection, with the ini-
tial weight loss recorded reversed after 5 days of treatment with 
the extracts in the prophylactic group, but not in the curative 
and suppressive groups, which showed progressive weight loss. 
This result in the suppressive and curative groups agrees with 
earlier report of continuous weight loss among treated animals 
compared with nontreated animals32 but disagrees with our 
previous study using extracts from Russelia equisetiformis, which 
showed a reversal in body weight after treatment.3 However, 
the prophylactic group in this study where we observed slight 
increase after treatment agrees with our previous study.
The survival time for mice in the prophylactic group 
extended beyond day 20, whereas those in the curative model 
did not survive beyond day 9. About 98% of the mice in the 
suppressive model were dead by day 15, with only 2% surviving 
till day 20 but not beyond, further confirming the prophylactic 
activity of B sapida ethanol extract.
Although there have been some reports of B sapida poison-
ing in people who consumed the fruit (ackee) in particular,33–37 
such poisonous effect was not observed with the stem bark 
used in our study. Histologic examination of the liver, kidney, 
and spleen showed no toxicity to the organs after treatment 
with the at all doses used, agreeing with the results 
Figure 5. graph showing survival time of mice in the 3 models.
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of a different study using Blighia unijugata, which showed no 
toxicity to the liver and kidney when administered in a dose-
dependent fashion to Wistar rats more than 4 weeks.38 
Histology of the testes reveals that extract has no toxic effect 
on male animals and as such not inhibitory to fertility. The dif-
ference in the reported toxicity may be due to the part of the 
plant examined. The seed is toxic, whereas the stem bark 
appears safe.
Conclusively, our results suggest that the ethanol bark 
extract of B sapida show some intrinsic antimalarial activities 
by its prophylactic ability against chloroquine-resistant P 
berghei parasites. This performance can surely be improved on 
in future studies if the crude extract is purified and the active 
substituents are identified and the doses further fractionated. 
The extracts have considerably low toxicities in experimental 
mice, this result supporting the traditional use of this plant for 
the prophylactic treatment of malaria only.
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